Like all medications, blinatumomab has potential side effects. Common side effects include fever, headache, infusion-related reactions, and low blood cell counts. More serious side effects can include cytokine release syndrome (CRS) and neurological toxicities, which may manifest as confusion, seizures, or encephalopathy. Close monitoring by healthcare providers is essential to manage these risks.
